knowledge -WSS

knowledge

author：explore 2025-09-30 12:18:29 - browse：954

A new treatment for Alzheimer’s disease developed by Eli Lilly slowed patients’ rate of cognitive and functional decline by 35% compared to placebo, the company said Wednesday, paving the way for a submission to the Food and Drug Administration and boosting hopes for a new class of Alzheimer’s drugs.

But the positive outcome of the study involving the drug, called donanemab, could be tempered by the deaths of two patients, and possibly a third, from a type of brain swelling caused by these drugs.

The results of the study were reported in a press release and have not yet been reviewed by outside scientists. Lilly said the data will be used to file for full approval with the FDA before the end of June. If cleared, donanemab will compete with another new Alzheimer’s treatment, Leqembi, made by Eisai and Biogen, that secured FDA approval in January.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

WSS

ProMED sees offers of support, but its future remains unclear

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

Why you get paid to donate plasma but not blood

New details revealed about Purdue's marketing of OxyContin

Evacuations in place as 3 wildfires burn in eastern Washington state

New details revealed about Purdue's marketing of OxyContin

explore

knowledge

entertainment

DIEP, the 'gold standard' of breast reconstruction, is under threat

Lack of darker skin in textbooks, journals harms patients of color

Medicare proposal to cover medical devices draws a mixed reaction

Clinical trials must include more disabled people

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

An interview with Robert F. Kennedy Jr. on vaccines

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Patient advocates sound warning on FDA proposal on salt intake

BioMarin wins approval for gene therapy to treat hemophilia A

Eye stem cell transplant could help restore vision in injured people

Wikipedia

ER docs worry over extreme heat as a 'mass casualty event'

ActiGraph execs on goal of drug approvals with digital endpoints

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

FDA seeking to stop procedures at two unregulated stem cell clinics

A strong 6.5

Lung cancer is America's deadliest cancer. Yet so few get screened

focus

hotspot

knowledge

hotspot